PMID: 8938265Feb 9, 1996Paper

Insulin receptor mRNA in the substantia nigra in Parkinson's disease

Neuroscience Letters
M TakahashiH Okada

Abstract

Neurotrophic effects resulting from the insulin/insulin receptor system have been recognized as important in determining the etiological basis of neurodegenerative disorders. In Parkinson's disease, selective neuronal loss in the substantia nigra is accompanied by decreased immunoreactivity of the insulin receptor as determined using immunohistochemical studies. We performed semiquantitative mRNA analysis by reverse transcription-polymerase chain reaction (RT-PCR) using specific primers for human insulin receptor exon 22, which encodes a region of the beta subunit of the receptor serving as a tyrosine kinase domain. The relative levels of mRNA in the substantia nigra from Parkinson's brain tissues showed a marked depression compared with those of normal controls. Further investigations are needed to decide whether this is a primary, disease-specific alteration of gene expression or merely a secondary process.

References

Sep 25, 1992·Nucleic Acids Research·H NakayamaJ Fujita
Sep 1, 1990·Diabetes·J M Olefsky
Feb 1, 1990·Diabetes·S SeinoG I Bell
Jan 1, 1988·Annual Review of Biochemistry·Y Yarden, A Ullrich
May 1, 1988·DNA·P E DanielsonJ G Sutcliffe
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T Hagg, S Varon
Jan 1, 1994·Progress in Growth Factor Research·K Unsicker

❮ Previous
Next ❯

Citations

Dec 13, 2000·Diabetes/metabolism Research and Reviews·P Freychet
Apr 22, 2010·Molecular Neurobiology·Raju V S Rajala, Robert E Anderson
Jan 22, 2013·Molecular Neurobiology·Rasoul GhasemiAbolhassan Ahmadiani
Jun 17, 2010·Neurotoxicity Research·Peter RiedererEdna Grünblatt
Dec 19, 2000·Neuroscience and Biobehavioral Reviews·R J SchulingkampR B Raffa
Jul 11, 2001·Neuroscience and Biobehavioral Reviews·C R Park
May 16, 2008·The Journal of Biological Chemistry·Ammaji RajalaRaju V S Rajala
Feb 22, 2012·Brain : a Journal of Neurology·Iciar Aviles-OlmosThomas Foltynie
Dec 1, 2011·Clinical and Experimental Pharmacology & Physiology·Ming Lu, Gang Hu
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K R WilhelmL A Morozova-Roche
Oct 24, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Dianne P Figlewicz, Stephen C Benoit
Mar 17, 2010·Neural Development·Shu-Ling Chiu, Hollis T Cline
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Jan 9, 2014·Journal of Neural Transmission·Mahesh Ramalingam, Sung-Jin Kim
Nov 21, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Xu-zhao LiFang Lu
May 7, 2003·Biochemical and Biophysical Research Communications·Masahiko KishimotoKazuo Chihara
May 24, 2012·ISRN Neurology·Khanh L Ng, Lan Nguyễn
Apr 20, 2016·Free Radical Biology & Medicine·Raquel Requejo-Aguilar, Juan P Bolaños
Oct 8, 2005·Journal of Pharmacological Sciences·Akihiko WadaHideyuki Kobayashi
Mar 6, 2012·Journal of the Neurological Sciences·Khanh vinh quôc Lu'o'ng, Lan Thi Hoàng Nguyên
Feb 5, 2013·Trends in Molecular Medicine·Jose A Santiago, Judith A Potashkin
Jun 3, 2009·Archives of Physiology and Biochemistry·Zvi Laron
Jun 28, 2014·Journal of Neuroimmunology·Lindsay J SpielmanAndis Klegeris
Feb 25, 2015·Diabetes/metabolism Research and Reviews·Daniel LazardKonstantin Bloch
Jul 7, 2009·Journal of Neurochemistry·Raju V S RajalaLuis E Politi
Jan 30, 2018·Nature Reviews. Neurology·Steven E ArnoldDavid M Nathan
Feb 3, 2011·British Journal of Clinical Pharmacology·Kawser AkterRobert B Raffa
May 16, 2013·The Journal of Biological Chemistry·Ammaji RajalaRaju V S Rajala
Dec 10, 2019·Journal of Parkinson's Disease·Allan K HansenPer Borghammer
Aug 2, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Sara C LaHueCaroline M Tanner
Jul 10, 2018·The Journal of Clinical Endocrinology and Metabolism·Seung Eun LeeUNKNOWN Taskforce Team for Diabetes Fact Sheet of the Korean Diabetes Association
Dec 4, 2019·Frontiers in Aging Neuroscience·Domenico SergiMaria-Grazia Martinoli
Jan 2, 2019·Brain Plasticity·Abdalla M AlbeelyMelissa L Perreault
Feb 24, 2019·International Journal of Molecular Sciences·Mitsuhiro MoritaMami Noda
Sep 19, 2018·Brain Sciences·Rashad HussainMuhammad Shahab
Apr 26, 2020·Journal of Parkinson's Disease·Julia L Y CheongAlastair J Noyce
Sep 3, 2019·Frontiers in Neuroscience·Francesca FioryFrancesco Oriente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.